NM_000767.5:c.296G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000767.5(CYP2B6):c.296G>A(p.Gly99Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,380,236 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.00039 ( 1 hom., cov: 29)
Exomes 𝑓: 0.00024 ( 0 hom. )
Consequence
CYP2B6
NM_000767.5 missense
NM_000767.5 missense
Scores
2
4
13
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0860
Publications
27 publications found
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008235216).
BS2
High AC in GnomAd4 at 47 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP2B6 | NM_000767.5 | c.296G>A | p.Gly99Glu | missense_variant | Exon 2 of 9 | ENST00000324071.10 | NP_000758.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CYP2B6 | ENST00000324071.10 | c.296G>A | p.Gly99Glu | missense_variant | Exon 2 of 9 | 1 | NM_000767.5 | ENSP00000324648.2 | ||
| CYP2B6 | ENST00000593831.1 | c.68G>A | p.Gly23Glu | missense_variant | Exon 1 of 5 | 2 | ENSP00000470582.1 | |||
| CYP2B6 | ENST00000598834.2 | n.197G>A | non_coding_transcript_exon_variant | Exon 2 of 10 | 5 | ENSP00000496294.1 |
Frequencies
GnomAD3 genomes AF: 0.000388 AC: 47AN: 121080Hom.: 1 Cov.: 29 show subpopulations
GnomAD3 genomes
AF:
AC:
47
AN:
121080
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000438 AC: 110AN: 251270 AF XY: 0.000427 show subpopulations
GnomAD2 exomes
AF:
AC:
110
AN:
251270
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000237 AC: 298AN: 1259110Hom.: 0 Cov.: 34 AF XY: 0.000253 AC XY: 158AN XY: 624072 show subpopulations
GnomAD4 exome
AF:
AC:
298
AN:
1259110
Hom.:
Cov.:
34
AF XY:
AC XY:
158
AN XY:
624072
show subpopulations
African (AFR)
AF:
AC:
0
AN:
27614
American (AMR)
AF:
AC:
21
AN:
38570
Ashkenazi Jewish (ASJ)
AF:
AC:
189
AN:
18876
East Asian (EAS)
AF:
AC:
0
AN:
20856
South Asian (SAS)
AF:
AC:
0
AN:
84444
European-Finnish (FIN)
AF:
AC:
0
AN:
35124
Middle Eastern (MID)
AF:
AC:
0
AN:
4702
European-Non Finnish (NFE)
AF:
AC:
53
AN:
981750
Other (OTH)
AF:
AC:
35
AN:
47174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
18
36
55
73
91
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000388 AC: 47AN: 121126Hom.: 1 Cov.: 29 AF XY: 0.000411 AC XY: 23AN XY: 55916 show subpopulations
GnomAD4 genome
AF:
AC:
47
AN:
121126
Hom.:
Cov.:
29
AF XY:
AC XY:
23
AN XY:
55916
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32162
American (AMR)
AF:
AC:
14
AN:
8382
Ashkenazi Jewish (ASJ)
AF:
AC:
23
AN:
3292
East Asian (EAS)
AF:
AC:
0
AN:
3640
South Asian (SAS)
AF:
AC:
0
AN:
3616
European-Finnish (FIN)
AF:
AC:
0
AN:
4786
Middle Eastern (MID)
AF:
AC:
0
AN:
172
European-Non Finnish (NFE)
AF:
AC:
6
AN:
62556
Other (OTH)
AF:
AC:
2
AN:
1662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
3
ExAC
AF:
AC:
45
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D;.
REVEL
Benign
Sift
Uncertain
.;D;.
Sift4G
Pathogenic
.;D;D
Polyphen
D;D;.
Vest4
0.18, 0.18
MVP
0.61
MPC
0.45
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.